A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men

C. Castro-Fernández, A. Olivares, D. Söderlund, J. C. López-Alvarenga, E. Zambrano, Johannes D Veldhuis, A. Ulloa-Aguirre, J. P. Méndez

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Hormonal abnormalities of the reproductive axis have been described in obesity. In men, extreme obesity is associated with low serum testosterone (T) and high estrogen [estrone and estradiol (E2)] levels. As changes in the sex steroid milieu may profoundly affect the carbohydrate heterogeneity and thus some of the biological and physicochemical properties of the LH molecule, we analyzed the relative distribution of LH isoforms circulating under baseline conditions (endogenous GnRH drive) as well as the forms discharged by exogenous GnRH stimulation from putative acutely releasable and reserve pituitary pools in overweight men. Secondarily, we determined the impact of the changes in LH terminal glycosylation on the in vitro bioactivity and endogenous half-life of the gonadotropin. Seven obese subjects with body mass indexes ranging from 35.7-45.5 kg/m2 and seven normal men with body mass indexes from 22.5-24.2 kg/m2 underwent blood sampling at 10-min intervals for a total of 10 h before and after the iv administration of 10 and 90 μg GnRH. Basally released and exogenous GnRH-stimulated serum LH isoforms were separated by preparative chromatofocusing and identified by RIA of eluent fractions. Serum pools of successive samples collected across 2-h intervals (five serum pools per subject) containing LH released under baseline and exogenous GnRH-stimulated conditions were tested for bioactivity employing a homologous in vitro bioassay. Mean serum T and E2 levels were significantly lower and higher, respectively, in the obese men than in the control group [serum T, 13.5 ± 2.4 vs. 19.4 ± 1.4 nmol/L (mean ± SEM; P = 0.01); serum E2, 0.184 ± 0.01 vs. 0.153 ± 0.01 nmol/L (P < 0.05)]. Mean baseline serum LH levels were similar in obese subjects and normal controls (13.3 ± 1.3 and 12.2 ± 1.2 IU/L). Although multiple parameter deconvolution of the exogenous GnRH-induced LH pulses revealed that the magnitude of the pituitary response in terms of secretory burst mass, secretory amplitude, and half-duration of the LH pulses was similar in obese and control subjects, the apparent endogenous half-life of LH was significantly (P < 0.05) shorter in the obese group (98 ± 11 min) than in the normal controls (132 ± 10 min). Under all conditions studied, the relative abundance of basic isoforms (those with pH ≥ 7.0) was significantly (P < 0.05) increased in the obese subjects compared with the controls (percentages of LH immunoactivity recovered at pH ≥7.0: obese subjects, 34-57%; normal controls, 22-46%). The biological to immunological ratio of LH released in baseline and low dose (10 μg) GnRH-stimulated conditions were similar in obese subjects and normal controls, whereas LH released by obese subjects in response to the high (90 μg) GnRH dose exhibited significantly lower ratios than those detected in normal individuals (0.62 ± 0.07 and 0.45 ± 0.09 vs. 1.01 ± 0.10 and 0.81 ± 0.09 for LH released within 10-120 min and 130-240 min after GnRH administration in obese and controls, respectively; P < 0.05). Collectively, these results indicate that the altered sex steroid hormone milieu characteristic of extreme obesity provokes a selective increase in the release of less acidic LH isoforms, which may potentially modify the intensity and duration of the blood LH signal delivered to the gonad. Altered glycosylation of LH may therefore represent an additional mechanism modulating the hypogonadal state prevailing in morbid obesity.

Original languageEnglish (US)
Pages (from-to)4603-4610
Number of pages8
JournalJournal of Clinical Endocrinology and Metabolism
Volume85
Issue number12
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Luteinizing Hormone
Gonadotropin-Releasing Hormone
Half-Life
Protein Isoforms
Plasmas
Serum
Glycosylation
Obesity
Bioactivity
Body Mass Index
Blood
Morbid Obesity
Bioassay
Estrone
Gonads
Gonadal Steroid Hormones
Deconvolution
Gonadotropins
Biological Assay
Testosterone

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men. / Castro-Fernández, C.; Olivares, A.; Söderlund, D.; López-Alvarenga, J. C.; Zambrano, E.; Veldhuis, Johannes D; Ulloa-Aguirre, A.; Méndez, J. P.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 85, No. 12, 2000, p. 4603-4610.

Research output: Contribution to journalArticle

Castro-Fernández, C. ; Olivares, A. ; Söderlund, D. ; López-Alvarenga, J. C. ; Zambrano, E. ; Veldhuis, Johannes D ; Ulloa-Aguirre, A. ; Méndez, J. P. / A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men. In: Journal of Clinical Endocrinology and Metabolism. 2000 ; Vol. 85, No. 12. pp. 4603-4610.
@article{053662f373114d1e9b26b6137689dc3e,
title = "A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men",
abstract = "Hormonal abnormalities of the reproductive axis have been described in obesity. In men, extreme obesity is associated with low serum testosterone (T) and high estrogen [estrone and estradiol (E2)] levels. As changes in the sex steroid milieu may profoundly affect the carbohydrate heterogeneity and thus some of the biological and physicochemical properties of the LH molecule, we analyzed the relative distribution of LH isoforms circulating under baseline conditions (endogenous GnRH drive) as well as the forms discharged by exogenous GnRH stimulation from putative acutely releasable and reserve pituitary pools in overweight men. Secondarily, we determined the impact of the changes in LH terminal glycosylation on the in vitro bioactivity and endogenous half-life of the gonadotropin. Seven obese subjects with body mass indexes ranging from 35.7-45.5 kg/m2 and seven normal men with body mass indexes from 22.5-24.2 kg/m2 underwent blood sampling at 10-min intervals for a total of 10 h before and after the iv administration of 10 and 90 μg GnRH. Basally released and exogenous GnRH-stimulated serum LH isoforms were separated by preparative chromatofocusing and identified by RIA of eluent fractions. Serum pools of successive samples collected across 2-h intervals (five serum pools per subject) containing LH released under baseline and exogenous GnRH-stimulated conditions were tested for bioactivity employing a homologous in vitro bioassay. Mean serum T and E2 levels were significantly lower and higher, respectively, in the obese men than in the control group [serum T, 13.5 ± 2.4 vs. 19.4 ± 1.4 nmol/L (mean ± SEM; P = 0.01); serum E2, 0.184 ± 0.01 vs. 0.153 ± 0.01 nmol/L (P < 0.05)]. Mean baseline serum LH levels were similar in obese subjects and normal controls (13.3 ± 1.3 and 12.2 ± 1.2 IU/L). Although multiple parameter deconvolution of the exogenous GnRH-induced LH pulses revealed that the magnitude of the pituitary response in terms of secretory burst mass, secretory amplitude, and half-duration of the LH pulses was similar in obese and control subjects, the apparent endogenous half-life of LH was significantly (P < 0.05) shorter in the obese group (98 ± 11 min) than in the normal controls (132 ± 10 min). Under all conditions studied, the relative abundance of basic isoforms (those with pH ≥ 7.0) was significantly (P < 0.05) increased in the obese subjects compared with the controls (percentages of LH immunoactivity recovered at pH ≥7.0: obese subjects, 34-57{\%}; normal controls, 22-46{\%}). The biological to immunological ratio of LH released in baseline and low dose (10 μg) GnRH-stimulated conditions were similar in obese subjects and normal controls, whereas LH released by obese subjects in response to the high (90 μg) GnRH dose exhibited significantly lower ratios than those detected in normal individuals (0.62 ± 0.07 and 0.45 ± 0.09 vs. 1.01 ± 0.10 and 0.81 ± 0.09 for LH released within 10-120 min and 130-240 min after GnRH administration in obese and controls, respectively; P < 0.05). Collectively, these results indicate that the altered sex steroid hormone milieu characteristic of extreme obesity provokes a selective increase in the release of less acidic LH isoforms, which may potentially modify the intensity and duration of the blood LH signal delivered to the gonad. Altered glycosylation of LH may therefore represent an additional mechanism modulating the hypogonadal state prevailing in morbid obesity.",
author = "C. Castro-Fern{\'a}ndez and A. Olivares and D. S{\"o}derlund and L{\'o}pez-Alvarenga, {J. C.} and E. Zambrano and Veldhuis, {Johannes D} and A. Ulloa-Aguirre and M{\'e}ndez, {J. P.}",
year = "2000",
doi = "10.1210/jc.85.12.4603",
language = "English (US)",
volume = "85",
pages = "4603--4610",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "12",

}

TY - JOUR

T1 - A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men

AU - Castro-Fernández, C.

AU - Olivares, A.

AU - Söderlund, D.

AU - López-Alvarenga, J. C.

AU - Zambrano, E.

AU - Veldhuis, Johannes D

AU - Ulloa-Aguirre, A.

AU - Méndez, J. P.

PY - 2000

Y1 - 2000

N2 - Hormonal abnormalities of the reproductive axis have been described in obesity. In men, extreme obesity is associated with low serum testosterone (T) and high estrogen [estrone and estradiol (E2)] levels. As changes in the sex steroid milieu may profoundly affect the carbohydrate heterogeneity and thus some of the biological and physicochemical properties of the LH molecule, we analyzed the relative distribution of LH isoforms circulating under baseline conditions (endogenous GnRH drive) as well as the forms discharged by exogenous GnRH stimulation from putative acutely releasable and reserve pituitary pools in overweight men. Secondarily, we determined the impact of the changes in LH terminal glycosylation on the in vitro bioactivity and endogenous half-life of the gonadotropin. Seven obese subjects with body mass indexes ranging from 35.7-45.5 kg/m2 and seven normal men with body mass indexes from 22.5-24.2 kg/m2 underwent blood sampling at 10-min intervals for a total of 10 h before and after the iv administration of 10 and 90 μg GnRH. Basally released and exogenous GnRH-stimulated serum LH isoforms were separated by preparative chromatofocusing and identified by RIA of eluent fractions. Serum pools of successive samples collected across 2-h intervals (five serum pools per subject) containing LH released under baseline and exogenous GnRH-stimulated conditions were tested for bioactivity employing a homologous in vitro bioassay. Mean serum T and E2 levels were significantly lower and higher, respectively, in the obese men than in the control group [serum T, 13.5 ± 2.4 vs. 19.4 ± 1.4 nmol/L (mean ± SEM; P = 0.01); serum E2, 0.184 ± 0.01 vs. 0.153 ± 0.01 nmol/L (P < 0.05)]. Mean baseline serum LH levels were similar in obese subjects and normal controls (13.3 ± 1.3 and 12.2 ± 1.2 IU/L). Although multiple parameter deconvolution of the exogenous GnRH-induced LH pulses revealed that the magnitude of the pituitary response in terms of secretory burst mass, secretory amplitude, and half-duration of the LH pulses was similar in obese and control subjects, the apparent endogenous half-life of LH was significantly (P < 0.05) shorter in the obese group (98 ± 11 min) than in the normal controls (132 ± 10 min). Under all conditions studied, the relative abundance of basic isoforms (those with pH ≥ 7.0) was significantly (P < 0.05) increased in the obese subjects compared with the controls (percentages of LH immunoactivity recovered at pH ≥7.0: obese subjects, 34-57%; normal controls, 22-46%). The biological to immunological ratio of LH released in baseline and low dose (10 μg) GnRH-stimulated conditions were similar in obese subjects and normal controls, whereas LH released by obese subjects in response to the high (90 μg) GnRH dose exhibited significantly lower ratios than those detected in normal individuals (0.62 ± 0.07 and 0.45 ± 0.09 vs. 1.01 ± 0.10 and 0.81 ± 0.09 for LH released within 10-120 min and 130-240 min after GnRH administration in obese and controls, respectively; P < 0.05). Collectively, these results indicate that the altered sex steroid hormone milieu characteristic of extreme obesity provokes a selective increase in the release of less acidic LH isoforms, which may potentially modify the intensity and duration of the blood LH signal delivered to the gonad. Altered glycosylation of LH may therefore represent an additional mechanism modulating the hypogonadal state prevailing in morbid obesity.

AB - Hormonal abnormalities of the reproductive axis have been described in obesity. In men, extreme obesity is associated with low serum testosterone (T) and high estrogen [estrone and estradiol (E2)] levels. As changes in the sex steroid milieu may profoundly affect the carbohydrate heterogeneity and thus some of the biological and physicochemical properties of the LH molecule, we analyzed the relative distribution of LH isoforms circulating under baseline conditions (endogenous GnRH drive) as well as the forms discharged by exogenous GnRH stimulation from putative acutely releasable and reserve pituitary pools in overweight men. Secondarily, we determined the impact of the changes in LH terminal glycosylation on the in vitro bioactivity and endogenous half-life of the gonadotropin. Seven obese subjects with body mass indexes ranging from 35.7-45.5 kg/m2 and seven normal men with body mass indexes from 22.5-24.2 kg/m2 underwent blood sampling at 10-min intervals for a total of 10 h before and after the iv administration of 10 and 90 μg GnRH. Basally released and exogenous GnRH-stimulated serum LH isoforms were separated by preparative chromatofocusing and identified by RIA of eluent fractions. Serum pools of successive samples collected across 2-h intervals (five serum pools per subject) containing LH released under baseline and exogenous GnRH-stimulated conditions were tested for bioactivity employing a homologous in vitro bioassay. Mean serum T and E2 levels were significantly lower and higher, respectively, in the obese men than in the control group [serum T, 13.5 ± 2.4 vs. 19.4 ± 1.4 nmol/L (mean ± SEM; P = 0.01); serum E2, 0.184 ± 0.01 vs. 0.153 ± 0.01 nmol/L (P < 0.05)]. Mean baseline serum LH levels were similar in obese subjects and normal controls (13.3 ± 1.3 and 12.2 ± 1.2 IU/L). Although multiple parameter deconvolution of the exogenous GnRH-induced LH pulses revealed that the magnitude of the pituitary response in terms of secretory burst mass, secretory amplitude, and half-duration of the LH pulses was similar in obese and control subjects, the apparent endogenous half-life of LH was significantly (P < 0.05) shorter in the obese group (98 ± 11 min) than in the normal controls (132 ± 10 min). Under all conditions studied, the relative abundance of basic isoforms (those with pH ≥ 7.0) was significantly (P < 0.05) increased in the obese subjects compared with the controls (percentages of LH immunoactivity recovered at pH ≥7.0: obese subjects, 34-57%; normal controls, 22-46%). The biological to immunological ratio of LH released in baseline and low dose (10 μg) GnRH-stimulated conditions were similar in obese subjects and normal controls, whereas LH released by obese subjects in response to the high (90 μg) GnRH dose exhibited significantly lower ratios than those detected in normal individuals (0.62 ± 0.07 and 0.45 ± 0.09 vs. 1.01 ± 0.10 and 0.81 ± 0.09 for LH released within 10-120 min and 130-240 min after GnRH administration in obese and controls, respectively; P < 0.05). Collectively, these results indicate that the altered sex steroid hormone milieu characteristic of extreme obesity provokes a selective increase in the release of less acidic LH isoforms, which may potentially modify the intensity and duration of the blood LH signal delivered to the gonad. Altered glycosylation of LH may therefore represent an additional mechanism modulating the hypogonadal state prevailing in morbid obesity.

UR - http://www.scopus.com/inward/record.url?scp=0034489817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034489817&partnerID=8YFLogxK

U2 - 10.1210/jc.85.12.4603

DO - 10.1210/jc.85.12.4603

M3 - Article

C2 - 11134115

AN - SCOPUS:0034489817

VL - 85

SP - 4603

EP - 4610

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 12

ER -